文献速递术前评估与围术期医学

止吐药给药与种族的关联:一项回顾性队列研究

Antiemetic Administration and Its Association with Race: A Retrospective Cohort Study.
PubMed 文献 · Anesthesiology · 2023-01-01

本研究基于2004至2018年多中心围术期结局组数据,分析种族与围术期止吐药给药的关系。在校正所有公认的术后恶心呕吐危险因素后,黑人患者较白人患者接受昂丹司琼或地塞米松的比例更低(58.5% vs 64.1%;校正比值比0.82;95%CI 0.81-0.82;P<0.001)。

要点

  • 黑人患者接受任何止吐药的比例低于白人患者(校正OR 0.82)。
  • 地塞米松、昂丹司琼单用及联用的给药率在黑人患者中均更低。
  • 校正Apfel危险因素后种族差异仍存在,提示需关注给药公平性。

核心结论

  • 在围术期注册数据集中,控制所有公认的术后恶心呕吐危险因素后,黑人患者较白人患者接受止吐药给药更少。

主要发现

  • 黑人患者接受昂丹司琼或地塞米松的比例为58.5%(290,208/496,456),白人患者为64.1%(2.24百万/3.49百万);校正OR 0.82;95%CI 0.81-0.82;P<0.001。
  • 黑人患者接受地塞米松的比例为28.3%(140,642/496,456),白人患者为37.0%(1.29百万/3.49百万);校正OR 0.78;95%CI 0.77-0.78;P<0.001。
  • 黑人患者接受昂丹司琼的比例为52.8%(262,086/496,456),白人患者为56.1%(1.96百万/3.49百万);校正OR 0.84;95%CI 0.84-0.85;P<0.001。
  • 黑人患者同时接受地塞米松和昂丹司琼的比例为22.7%(112,520/496,456),白人患者为28.9%(1.0百万/3.49百万);校正OR 0.78;95%CI 0.77-0.79;P<0.001。

关键数值与推荐

  • 主要结局为昂丹司琼或地塞米松给药;次要结局为各药单独或联合给药。
  • 校正因素包括Apfel术后恶心呕吐危险因素(性别、吸烟史、术后恶心呕吐或晕动病史、术后阿片类药物使用)及年龄,机构作为随机效应。

临床怎么用

  • 麻醉科医生应意识到种族差异可能影响止吐药给药,在临床决策中注意评估并减少差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anesthesiologists' contribution to perioperative healthcare disparities remains unclear because patient and surgeon preferences can influence care choices. Postoperative nausea and vomiting is a patient- centered outcome measure and a main driver of unplanned admissions. Antiemetic administration is under the sole domain of anesthesiologists. In a U.S. sample, Medicaid insured versus commercially insured patients and those with lower versus higher median income had reduced antiemetic administration, but not all risk factors were controlled for. This study examined whether a patient's race is associated with perioperative antiemetic administration and hypothesized that Black versus White race is associated with reduced receipt of antiemetics. METHODS: An analysis was performed of 2004 to 2018 Multicenter Perioperative Outcomes Group data. The primary outcome of interest was administration of either ondansetron or dexamethasone; secondary outcomes were administration of each drug individually or both drugs together. The confounder-adjusted analysis included relevant patient demographics (Apfel postoperative nausea and vomiting risk factors: sex, smoking history, postoperative nausea and vomiting or motion sickness history, and postoperative opioid use; as well as age) and included institutions as random effects. RESULTS: The Multicenter Perioperative Outcomes Group data contained 5.1 million anesthetic cases from 39 institutions located in the United States and The Netherlands. Multivariable regression demonstrates that Black patients were less likely to receive antiemetic administration with either ondansetron or dexamethasone than White patients (290,208 of 496,456 [58.5%] vs. 2.24 million of 3.49 million [64.1%]; adjusted odds ratio, 0.82; 95% CI, 0.81 to 0.82; P < 0.001). Black as compared to White patients were less likely to receive any dexamethasone (140,642 of 496,456 [28.3%] vs. 1.29 million of 3.49 million [37.0%]; adjusted odds ratio, 0.78; 95% CI, 0.77 to 0.78; P < 0.001), any ondansetron (262,086 of 496,456 [52.8%] vs. 1.96 million of 3.49 million [56.1%]; adjusted odds ratio, 0.84; 95% CI, 0.84 to 0.85; P < 0.001), and dexamethasone and ondansetron together (112,520 of 496,456 [22.7%] vs. 1.0 million of 3.49 million [28.9%]; adjusted odds ratio, 0.78; 95% CI, 0.77 to 0.79; P < 0.001). CONCLUSIONS: In a perioperative registry data set, Black versus White patient race was associated with less antiemetic administration, after controlling for all accepted postoperative nausea and vomiting risk factors.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. White RS, Andreae MH, Lui B, et al. Antiemetic Administration and Its Association with Race: A Retrospective Cohort Study. Anesthesiology. 2023. PMID: 37158649. doi:10.1097/ALN.0000000000004549

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。